These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 15297390)

  • 1. Biological relevance of adduct detection to the chemoprevention of cancer.
    Sharma RA; Farmer PB
    Clin Cancer Res; 2004 Aug; 10(15):4901-12. PubMed ID: 15297390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.
    Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD
    Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
    Kensler TW; Groopman JD
    J Cell Biochem Suppl; 1996; 25():85-91. PubMed ID: 9027603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogen biomarkers for lung or oral cancer chemoprevention trials.
    Hecht SS
    IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans.
    Nair U; Bartsch H; Nair J
    Free Radic Biol Med; 2007 Oct; 43(8):1109-20. PubMed ID: 17854706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies.
    Pathak SK; Sharma RA; Steward WP; Mellon JK; Griffiths TR; Gescher AJ
    Eur J Cancer; 2005 Jan; 41(1):61-70. PubMed ID: 15617991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uses of carcinogen-DNA adduct measurement in establishing mechanisms of mutagenesis and in chemoprevention.
    Baird WM; Mahadevan B
    Mutat Res; 2004 Mar; 547(1-2):1-4. PubMed ID: 15013693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention.
    De Flora S; Balansky R; Scatolini L; Di Marco C; Gasparini L; Orlando M; Izzotti A
    IARC Sci Publ; 1996; (139):291-301. PubMed ID: 8923039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
    Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
    Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA markers of oxidative processes in vivo: relevance to carcinogenesis and anticarcinogenesis.
    Simic MG
    Cancer Res; 1994 Apr; 54(7 Suppl):1918s-1923s. PubMed ID: 8137312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
    Farmer PB; Singh R
    Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exocyclic DNA adducts as oxidative stress markers in colon carcinogenesis: potential role of lipid peroxidation, dietary fat and antioxidants.
    Bartsch H; Nair J; Owen RW
    Biol Chem; 2002 Jun; 383(6):915-21. PubMed ID: 12222681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials.
    Scott EN; Gescher AJ; Steward WP; Brown K
    Cancer Prev Res (Phila); 2009 Jun; 2(6):525-30. PubMed ID: 19470784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure biomarkers for the study of toxicological impact on carcinogenic processes.
    Farmer PB
    IARC Sci Publ; 2004; (157):71-90. PubMed ID: 15055291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preventive medicine: biomonitoring and chemoprevention].
    Tompa A; Szende B
    Magy Onkol; 2002; 46(2):147-53. PubMed ID: 12202894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis.
    Valavanidis A; Vlachogianni T; Fiotakis C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):120-39. PubMed ID: 19412858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
    Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
    Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.